<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01100216</url>
  </required_header>
  <id_info>
    <org_study_id>2009NTLS097</org_study_id>
    <secondary_id>0911M74614</secondary_id>
    <nct_id>NCT01100216</nct_id>
  </id_info>
  <brief_title>Human Laboratory Study of Smokeless Tobacco Products</brief_title>
  <official_title>Human Laboratory Study of Smokeless Tobacco Products</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the advent of restrictions on public smoking, the tobacco industry has introduced a
      variety of novel smokeless tobacco products (NSTP) to allow continued tobacco use. These
      products typically have lower tobacco-specific nitrosamines, carcinogens and nicotine than
      conventional smokeless products out on the market. No studies have compared the effects of
      NSTP and medicinal nicotine products (MNP) in smokeless tobacco users and whether some of the
      NSTP products may serve as a cessation tool for smokeless tobacco users. Our hypothesis is
      that the effects from these products will be directly related to their nicotine content and
      sensory effects. Products that produce greater effects on outcome measures may serve as
      potential cessation tools.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment will be a 3-period crossover study using Commit Nicotine Lozenge, Stonewall
      Disposable Tobacco Pieces and Camel Snus Frost Pouches. Each period will last 14 days with 11
      days of product use and 1.5 days abstinence of all nicotine-containing products for a total
      of 10 weeks. Participants will begin the study by completing a baseline assessment on their
      own product, Skoal Wintergreen.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Funding expired prior to implementing subject recruitment.
  </why_stopped>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Withdrawal Severity</measure>
    <time_frame>Week 10</time_frame>
    <description>Comparing withdrawal symptoms between the different products - 4 mg nicotine lozenge (LOZ), Camel Snus Frost (SNUS), Stonewall Spearmint Tablet (STAB), and Skoal Wintergreen (SKOL).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognition Impairments</measure>
    <time_frame>Week 10</time_frame>
    <description>Comparing differences between the smokeless tobacco products - 4 mg nicotine lozenge (LOZ), Camel Snus Frost (SNUS), Stonewall Spearmint Tablet (STAB), and Skoal Wintergreen (SKOL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Startle Response</measure>
    <time_frame>Week 10</time_frame>
    <description>Negative emotional responses to nicotine-relevant stimulant (based on physiologoical and electrophysiological measures, and self-reports of affective valence, arousal and control/dominance) differences between products - 4 mg nicotine lozenge (LOZ), Camel Snus Frost (SNUS), Stonewall Spearmint Tablet (STAB), and Skoal Wintergreen (SKOL).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinforcement</measure>
    <time_frame>Week 10</time_frame>
    <description>The break point (response workload at which subjects do not respond sufficiently to obtain a dosage of product in a defined time period) is expected to differ significantly between products - 4 mg nicotine lozenge (LOZ), Camel Snus Frost (SNUS), Stonewall Spearmint Tablet (STAB), and Skoal Wintergreen (SKOL).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Smokeless Tobacco</condition>
  <arm_group>
    <arm_group_label>Nicotine Lozenge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>4 mg nicotine lozenge (LOZ</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Camel Snus Frost</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Stonewall Spearment Tablet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Skoal Wintergreen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nicotine Lozenge</intervention_name>
    <description>4 mg for 12 days</description>
    <arm_group_label>Nicotine Lozenge</arm_group_label>
    <other_name>Commit Nicotine Lozenge</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stonewall Dissolvable Tobacco Pieces</intervention_name>
    <description>5.6 mg nicotine pieces for 12 days</description>
    <arm_group_label>Stonewall Spearment Tablet</arm_group_label>
    <other_name>Stonewall Spearmint Tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Camel Snus Frost</intervention_name>
    <description>pouches, 6.2 mg nicotine, for 12 days</description>
    <arm_group_label>Camel Snus Frost</arm_group_label>
    <other_name>Camel Snus Frost Pouches</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Skoal Wintergreen</intervention_name>
    <description>Used at baseline (Days 1 and 2, 5-11) and then at every 7 day wash-out period.</description>
    <arm_group_label>Skoal Wintergreen</arm_group_label>
    <other_name>Skoal</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects will be 20 male smokeless tobacco (SLT) users who are not seeking to quit
             (less than 5% of females use SLT.

          -  Subjects will be Skoal Wintergreen SLT users, since this is the most commonly used SLT
             that uses a mint-type flavorant.

          -  Subjects will have used SLT for at least 1 year..

          -  Subjects will be English speaking and reading.

          -  Provide written informed consent.

        Exclusion Criteria:

          -  Subjects who have used other tobacco products (i.e., cigarettes, cigars) or nicotine
             products in past 6 months.

          -  Subjects who take medications that might affect the outcome of laboratory measures.

          -  Subjects with a history of major mood, thought, anxiety or attentional disorders.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Mooney, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Psychiatry, University of Minnesota</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tobacco Research Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2010</study_first_submitted>
  <study_first_submitted_qc>April 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 8, 2010</study_first_posted>
  <last_update_submitted>December 9, 2014</last_update_submitted>
  <last_update_submitted_qc>December 9, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smokeless tobacco</keyword>
  <keyword>nicotine</keyword>
  <keyword>snus</keyword>
  <keyword>snuff</keyword>
  <keyword>chewing tobacco</keyword>
  <keyword>oral tobacco</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

